MONODAC
Protein degraders for the prevention and treatment of human diseases and conditions, namely, cancer, tumors, neurological diseases and disorders, hematological diseases and disorders, pharmaceutical products for the prevention and treatment of cancer, tumors, neurological, pharmaceutical preparations for immunotherapy
Registered · July 13, 2020 · 90049843 ·